Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2007

Conditions
Healthy
Interventions
DRUG

Single rising doses of BI 1744 CL, solution for oral inhalation

DRUG

Tiotropium, fixed dose, solution for oral inhalation

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY